格伦马克制药公司2025年10月3日前股息,中期支付2.50美元,因利下降和美国关税问题. Glenmark Pharma ex-dividend Oct. 3, 2025, with ₹2.50 interim payout, amid profit drop and U.S. tariff concerns.

Glenmark制药公司将在2025年10月3日进行前期交易,在记录日期向股东支付每股2.50英镑的临时红利。 Glenmark Pharmaceuticals will trade ex-dividend on October 3, 2025, with an interim dividend of ₹2.50 per share payable to shareholders on the record date. 尽管净利润逐年急剧下降,收入略有下降,但该公司报告EBITDA的利润率很高。 Despite a sharp year-on-year drop in net profit and a slight revenue decline, the company reported strong EBITDA margins. 近几个月来,由于预期美国从10月1日起对品牌药品征收关税,该库存虽然面临更广泛的部门挑战,但仍略有增长。 The stock has seen modest gains over recent months, though it faces broader sector challenges due to anticipated U.S. tariffs on branded drugs starting October 1. 包括Paushak Ltd和GEE Ltd在内的其他公司正在实施奖金问题和股本分割,而一些公司正在减少资本、解决正确的问题或暂停交易。 Other companies, including Paushak Ltd and GEE Ltd, are implementing bonus issues and stock splits, while several firms are conducting capital reductions, right issues, or suspending trading. 这些企业行动定于2025年9月29日至10月3日进行。 These corporate actions are scheduled from September 29 to October 3, 2025.